References
- Chow , S. C. , Shao , J. and Hu , O. Y. P. 2002 . Assessing sensitivity and similarity in bridging studies . J. Biopharm. Statist. , 12 : 385 – 400 . [CSA]
- 1998 . ICH, International Conference on Harmonisation. Tripartite Guidance E5 Ethnic Factors in the Acceptability of Foreign Data, The U.S. Federal Register 83:31790–31796
- Liu , J. P. and Chow , S. C. 2002 . Bridging studies for clinical development . J. Biopharm. Statist. , 12 : 357 – 369 .
- Liu , J. P. , Hsiao , C.-F. and Hsueh , H.-M. 2002a . Bayesian approach to evaluation of bridging studies . J. Biopharm. Statist. , 12 : 401 – 408 . [CSA] [CROSSREF]
- Liu , J. P. , Hsueh , H.-M. and Chen , J. J. 2002b . Sample size requirement for evaluation of bridging evidence . Biometrical J. , 44 : 969 – 981 . [CROSSREF]
- Shih , W. J. 2001 . Clinical trials for drug registration in Asian-Pacific countries: Proposal for a new paradigm from a statistical perspective . Control. Clin. Trials , 22 : 357 – 366 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
- Simon . 1999 . Bayesian design and analysis of active control trials . Biometrics , 55 : 484 – 487 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
- #The views expressed in this article are personal opinions of the authors and may not necessarily represent the position of the National Health Research Institutes, National Cheng-Chi University, and National Cheng Kung University, Taiwan.